BEDFORD, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight ...
Findings from pediatric trials showed left ventricular opacification with Definity was successful and provided important information to guide patient management. The Food and Drug Administration (FDA) ...
Screening for prostate cancer: A systematic review and meta-analysis. Background: A novel ultrasound method employing microbubble (MB) contrast offers portable, noninvasive dynamic assessment of tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results